Lung Cancer Trial, Recruiting (NCT04527419)

Lung Cancer Trial, Recruiting NCT04527419 Sponsor: Fudan University Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04527419 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Your cancer has been identified as an early stage (stage T1N0M0) and you are planned to have surgery to remove it with the goal of a cure.
A scan (CT scan) shows only one spot in the lung that appears mostly as a "ground glass" shadow (a faint, hazy area), with the solid part making up no more than half of the total spot size.
You are between 18 and 75 years old.
You have read and signed the consent form agreeing to take part in the trial.

Who may not be able to join:

After surgery, if the tissue sample shows a cancer type other than invasive adenocarcinoma (a specific type of lung cancer), you may not be eligible.
If you have a smaller type of surgery called a "wedge resection" but your tumor does not meet both of these specific size conditions — the solid part being no more than 25% of the total tumor size AND the total tumor being no larger than 2 cm — you may not be eligible (confirm with trial site).
Your surgery did not completely remove the cancer, or was not done with the goal of a cure.
You have a history of any other type of cancer.
You have previously had surgery on your chest or lungs.
You have previously received radiation therapy, chemotherapy, or any other cancer treatments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Haiquan Chen, Ph.D, Shanghai Cancer Center

Phone: 86-13901770461

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04527419

Sponsor: Fudan University

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: 86-13901770461

More information: https://clinicaltrials.gov/study/NCT04527419

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Your cancer has been identified as an early stage (stage T1N0M0) and you are planned to have surgery to remove it with the goal of a cure.
A scan (CT scan) shows only one spot in the lung that appears mostly as a "ground glass" shadow (a faint, hazy area), with the solid part making up no more than half of the total spot size.
You are between 18 and 75 years old.
You have read and signed the consent form agreeing to take part in the trial.

Who may not be able to join:

After surgery, if the tissue sample shows a cancer type other than invasive adenocarcinoma (a specific type of lung cancer), you may not be eligible.
If you have a smaller type of surgery called a "wedge resection" but your tumor does not meet both of these specific size conditions — the solid part being no more than 25% of the total tumor size AND the total tumor being no larger than 2 cm — you may not be eligible (confirm with trial site).
Your surgery did not completely remove the cancer, or was not done with the goal of a cure.
You have a history of any other type of cancer.
You have previously had surgery on your chest or lungs.
You have previously received radiation therapy, chemotherapy, or any other cancer treatments.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fudan University

Registry

ClinicalTrials.gov

Start date

9 February 2022

Est. completion

21 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov